Annual Accounts Payable
$7.32 M
-$6.63 M-47.54%
31 December 2023
Summary:
Mersana Therapeutics annual accounts payable is currently $7.32 million, with the most recent change of -$6.63 million (-47.54%) on 31 December 2023. During the last 3 years, it has fallen by -$1.02 million (-12.24%). MRSN annual accounts payable is now -47.54% below its all-time high of $13.95 million, reached on 31 December 2022.MRSN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.03 M
-$980.00 K-32.53%
30 September 2024
Summary:
Mersana Therapeutics quarterly accounts payable is currently $2.03 million, with the most recent change of -$980.00 thousand (-32.53%) on 30 September 2024. Over the past year, it has dropped by -$10.91 million (-84.30%). MRSN quarterly accounts payable is now -88.80% below its all-time high of $18.16 million, reached on 31 March 2023.MRSN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.5% | -84.3% |
| 3 y3 years | -12.2% | -65.3% |
| 5 y5 years | -31.8% | -72.2% |
MRSN Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.5% | at low | -88.8% | at low |
| 5 y | 5 years | -47.5% | +0.3% | -88.8% | at low |
| alltime | all time | -47.5% | +261.4% | -88.8% | +12.9% |
Mersana Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.03 M(-32.5%) |
| June 2024 | - | $3.01 M(-2.4%) |
| Mar 2024 | - | $3.09 M(-57.8%) |
| Dec 2023 | $7.32 M(-47.5%) | $7.32 M(-43.5%) |
| Sept 2023 | - | $12.95 M(-23.5%) |
| June 2023 | - | $16.92 M(-6.8%) |
| Mar 2023 | - | $18.16 M(+30.1%) |
| Dec 2022 | $13.95 M(+13.2%) | $13.95 M(+1.6%) |
| Sept 2022 | - | $13.73 M(+68.3%) |
| June 2022 | - | $8.16 M(-16.5%) |
| Mar 2022 | - | $9.78 M(-20.7%) |
| Dec 2021 | $12.32 M(+47.7%) | $12.32 M(+110.0%) |
| Sept 2021 | - | $5.87 M(-44.9%) |
| June 2021 | - | $10.65 M(-9.3%) |
| Mar 2021 | - | $11.74 M(+40.8%) |
| Dec 2020 | $8.34 M | $8.34 M(+84.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $4.53 M(-36.8%) |
| June 2020 | - | $7.16 M(+55.5%) |
| Mar 2020 | - | $4.60 M(-36.9%) |
| Dec 2019 | $7.30 M(-32.0%) | $7.30 M(-0.1%) |
| Sept 2019 | - | $7.30 M(+12.1%) |
| June 2019 | - | $6.52 M(-6.4%) |
| Mar 2019 | - | $6.96 M(-35.1%) |
| Dec 2018 | $10.73 M(+249.4%) | $10.73 M(+59.4%) |
| Sept 2018 | - | $6.73 M(+61.8%) |
| June 2018 | - | $4.16 M(+64.9%) |
| Mar 2018 | - | $2.52 M(-17.9%) |
| Dec 2017 | $3.07 M(+48.5%) | $3.07 M(-4.5%) |
| Sept 2017 | - | $3.21 M(+72.7%) |
| June 2017 | - | $1.86 M(+3.4%) |
| Mar 2017 | - | $1.80 M(-12.9%) |
| Dec 2016 | $2.07 M(+2.1%) | $2.07 M |
| Dec 2015 | $2.02 M | - |
FAQ
- What is Mersana Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Mersana Therapeutics?
- What is Mersana Therapeutics annual accounts payable year-on-year change?
- What is Mersana Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly accounts payable year-on-year change?
What is Mersana Therapeutics annual accounts payable?
The current annual accounts payable of MRSN is $7.32 M
What is the all time high annual accounts payable for Mersana Therapeutics?
Mersana Therapeutics all-time high annual accounts payable is $13.95 M
What is Mersana Therapeutics annual accounts payable year-on-year change?
Over the past year, MRSN annual accounts payable has changed by -$6.63 M (-47.54%)
What is Mersana Therapeutics quarterly accounts payable?
The current quarterly accounts payable of MRSN is $2.03 M
What is the all time high quarterly accounts payable for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly accounts payable is $18.16 M
What is Mersana Therapeutics quarterly accounts payable year-on-year change?
Over the past year, MRSN quarterly accounts payable has changed by -$10.91 M (-84.30%)